Regulatory Submissions for Novel CDx: A Case Study of CDx & Drug Co-Development

• Traditional regulatory pathway for CDx co-development in Japan
• Companion vs. complementary diagnostics
• Libtayo approval lessons learned

Speakers:

Elnaz jokar

Senior Manager - Regulatory Affairs

Regeneron Pharmaceuticals